COVID-19 Case Surveillance Public Use Data with Geography
COVID-19 Case Surveillance Public Use Data with Geography
This case surveillance public use dataset has 19 elements for all COVID-19 cases shared with CDC and includes demographics, geography (county and state of residence), any exposure history, disease severity indicators and outcomes, and presence of any underlying medical conditions and risk behaviors.
Currently, CDC provides the public with three versions of COVID-19 case surveillance line-listed data: this <a href="https://data.cdc.gov/Case-Surveillance/COVID-19-Case-Surveillance-Public-Use-Data-with-Ge/n8mc-b4w4">19 data element dataset with geography</a>, a <a href="https://data.cdc.gov/Case-Surveillance/COVID-19-Case-Surveillance-Public-Use-Data/vbim-akqf">12 data element public use dataset</a>, and a <a href="https://data.cdc.gov/Case-Surveillance/COVID-19-Case-Surveillance-Restricted-Access-Detai/mbd7-r32t">32 data element restricted access dataset</a>.
The following apply to the public use datasets and the restricted access dataset:
Data elements can be found on the COVID-19 case report form located at <a href="https://www.cdc.gov/coronavirus/2019-ncov/downloads/pui-form.pdf">www.cdc.gov/coronavirus/2019-ncov/downloads/pui-form.pdf</a>.
Data are considered provisional by CDC and are subject to change until the data are reconciled and verified with the state and territorial data providers.
Some data are suppressed to protect individual privacy.
Datasets will include all cases with the earliest date available in each record (date received by CDC or date related to illness/specimen collection) at least 14 days prior to the creation of the previously updated datasets. This 14-day lag allows case reporting to be stabilized and ensure that time-dependent outcome data are accurately captured.
Datasets are updated monthly.
Datasets are created using CDC’s <a href="https://www.cdc.gov/maso/policy/policy385.pdf">Policy on Public Health Research and Nonresearch Data Management and Access</a> and include protections designed to protect individual privacy.
For more information about data collection and reporting, please see <a href="https://wwwn.cdc.gov/nndss/data-collection.html">wwwn.cdc.gov/nndss/data-collection.html</a>.
For more information about the COVID-19 case surveillance data, please see <a href="https://www.cdc.gov/coronavirus/2019-ncov/covid-data/faq-surveillance.html">www.cdc.gov/coronavirus/2019-ncov/covid-data/faq-surveillance.html</a>.
The COVID-19 case surveillance database includes patient-level data reported by U.S. states and autonomous reporting entities, including New York City and the District of Columbia (D.C.), as well as U.S. territories and affiliates. On April 5, 2020, COVID-19 was added to the <a href="https://wwwn.cdc.gov/nndss/conditions/">Nationally Notifiable Condition List</a> and classified as "immediately notifiable, urgent (within 24 hours)" by a Council of State and Territorial Epidemiologists (CSTE) Interim Position Statement (<a href="https://www.cste.org/resource/resmgr/ps/positionstatement2020/Interim-20-ID-01_COVID-19_NO.pdf">Interim-20-ID-01</a>). CSTE updated the position statement on August 5, 2020 to clarify the interpretation of antigen detection tests and serologic test results within the case classification (<a href="https://www.cste.org/resource/resmgr/ps/positionstatement2020/Interim-20-ID-02_COVID-19.pdf">Interim-20-ID-02</a>). The statement also recommended that all states and territories enact laws to make COVID-19 reportable in their jurisdiction, and that jurisdictions conducting surveillance should submit case notifications to CDC. COVID-19 case surveillance data collected by jurisdictions are shared voluntarily with CDC.
For more information, visit: <a href="https://wwwn.cdc.gov/nndss/conditions/coronavirus-disease-2019-covid-19/case-definition/2020/08/05/">wwwn.cdc.gov/nndss/conditions/coronavirus-disease-2019-covid-19/case-definition/2020/08/05/</a>.
<b>COVID-19 Case Reports</b>
COVID-19 case reports are routinely submitted to CDC by pu
|Name||Socrata field name||Column name in ||Data type||Description|
|age_group||age_group||age_group||Text||Age group 0 - 17 years; 18 - 49 years; 50 - 64 years; 65 + years; Unknown; Missing; NA, if value suppressed for privacy protection.|
|ethnicity||ethnicity||ethnicity||Text||Ethnicity Hispanic; Non-Hispanic; Unknown; Missing; NA, if value suppressed for privacy protection.|
|exposure_yn||exposure_yn||exposure_yn||Text||In the 14 days prior to illness onset, did the patient have any of the following known exposures: domestic travel, international travel, cruise ship or vessel travel as a passenger or crew member, workplace, airport/airplane, adult congregate living facility (nursing, assisted living, or long-term care facility), school/university/childcare center, correctional facility, community event/mass gathering, animal with confirmed or suspected COVID-19, other exposure, contact with a known COVID-19 case? Yes, Unknown, Missing|
|process||process||process||Text||Under what process was the case first identified? Clinical evaluation; Routine surveillance; Contact tracing of case patient; Multiple; Other; Unknown; Missing|
|symptom_status||symptom_status||symptom_status||Text||What is the symptom status of this person? Asymptomatic, Symptomatic, Unknown, Missing|
|case_onset_interval||case_onset_interval||case_onset_interval||Number||Weeks between earliest date and date of symptom onset.|
|case_month||case_month||case_month||Text||The earlier of month the Clinical Date (date related to the illness or specimen collection) or the Date Received by CDC|
|icu_yn||icu_yn||icu_yn||Text||Was the patient admitted to an intensive care unit (ICU)? Yes, No, Unknown, Missing|
|hosp_yn||hosp_yn||hosp_yn||Text||Was the patient hospitalized? Yes, No, Unknown, Missing|
|state_fips_code||state_fips_code||state_fips_code||Text||State FIPS code|
|underlying_conditions_yn||underlying_conditions_yn||underlying_conditions_yn||Text||Did the patient have one or more of the underlying medical conditions and risk behaviors: diabetes mellitus, hypertension, severe obesity (BMI>40), cardiovascular disease, chronic renal disease, chronic liver disease, chronic lung disease, other chronic diseases, immunosuppressive condition, autoimmune condition, current smoker, former smoker, substance abuse or misuse, disability, psychological/psychiatric, pregnancy, other. Yes, No, blank|
|current_status||current_status||current_status||Text||What is the current status of this person? Laboratory-confirmed case, Probable case|
|race||race||race||Text||Race American Indian/Alaska Native; Asian; Black; Multiple/Other; Native Hawaiian/Other Pacific Islander; White; Unknown; Missing; NA, if value suppressed for privacy protection.|
|case_positive_specimen_interval||case_positive_specimen||case_positive_specimen||Number||Weeks between earliest date and date of first positive specimen collection|
|res_state||res_state||res_state||Text||State of residence|
|res_county||res_county||res_county||Text||County of residence|
|county_fips_code||county_fips_code||county_fips_code||Text||County FIPS code|
|sex||sex||sex||Text||Sex Female; Male; Other; Unknown; Missing; NA, if value suppressed for privacy protection.|
|death_yn||death_yn||death_yn||Text||Did the patient die as a result of this illness? Yes; No; Unknown; Missing; NA, if value suppressed for privacy protection.|